People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MiNDERA Corp | — | Biotechnology | Series B | $25.9M | $165.4M | 2022 |
| Circular Genomics Inc. | — | Biotechnology | Series A | $12.6M | $54.6M | 2021 |
| Pathfinder Therapeutics, Inc. | — | Other Health Care | Series A | $12.6M | $25.1M | 2013 |
| VenX, LLC | — | Other Health Care | Seed | $3.7M | $10.3M | 2013 |
Joseph Cook III at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph Cook III on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Harris | 1 | 20 |
| David Blivin | 1 | 14 |
| Clay Thorp | 1 | 10 |
| Navroze Mehta | 1 | 8 |
| Richard Molloy | 1 | 7 |
| Brian Laden | 1 | 7 |
| Patrick Rivelli | 1 | 6 |
| Waneta Tuttle | 1 | 6 |
| Andrew ` Offer | 1 | 5 |
| Hans Hickler | 1 | 5 |
| Joseph C. Cook, III | 1 | 4 |
| Marc Buntaine | 1 | 3 |
| Deborah Johnson | 1 | 3 |
| Jerry Gibson | 1 | 3 |
| Naji Abumrad | 1 | 3 |
| Robert Morff | 1 | 2 |
| George Mahaffey | 1 | 2 |
| Ron Rocca | 1 | 2 |
| Cathy Petti | 1 | 2 |
| Alexander Hafez | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.